| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.01.23 | Nicox - Q4 highlights confirm continued Vyzulta growth | 574 | Edison Investment Research | Nicox has provided a preliminary Q422 update, reporting a c 38% y-o-y increase in FY22 net royalty payments to €3.3m, including a c 100% y-o-y elevation in Q422 net royalties to €1.0m. Nicox receives... ► Artikel lesen | |
| 19.01.23 | OpGen - FY22 wrap offers key operational takeaways | 483 | Edison Investment Research | OpGen has announced preliminary FY22 results and provided a business update ahead of the detailed FY22 report expected in March 2023. Group revenue came in at $2.7m, slightly below the mid-point of... ► Artikel lesen | |
| 19.01.23 | Creo Medical - Progressing on all fronts | 447 | Edison Investment Research | 2022 was an eventful year for Creo Medical, as it progressed on all fronts of its 'Build, Buy and Partner' strategy. The period was marked by the increasing traction of Speedboat Inject (its flagship... ► Artikel lesen | |
| 19.01.23 | Secure Trust Bank - In line, with good momentum | 285 | Edison Investment Research | In its FY22 post-close trading update, Secure Trust Bank (STB) announced that business has been trading in line with management expectations and with good momentum. Continuing profit before taxes and... ► Artikel lesen | |
| 19.01.23 | Supermarket Income REIT - SUPR takes majority interest in indirect portfolio | 345 | Edison Investment Research | Supermarket Income REIT (SUPR) has acquired an additional 25.5% beneficial interest in the Sainsbury's Reversion Portfolio (SRP) from its joint venture (JV) partner. It now has a 51% interest with 49%... ► Artikel lesen | |
| 19.01.23 | Centaur Media - Strong cash performance and special dividend | 214 | Edison Investment Research | Centaur's year-end trading update indicates revenue of at least £41m and an EBITDA margin of more than 19.5%. Our FY22e EBITDA, PBT and EPS numbers are unchanged, showing strong growth over the prior... ► Artikel lesen | |
| 19.01.23 | Incannex Healthcare - Progressing the opportunity in anxiety treatment | 303 | Edison Investment Research | Following continued patient enrolment in Incannex's ongoing Australian Phase II Psi-GAD1 study (ACTRN12621001358831), management has announced the commencement of an independent analysis of the interim... ► Artikel lesen | |
| 19.01.23 | Esker - Order momentum maintained in Q422 | 399 | Edison Investment Research | Esker's Q422 revenue update confirmed that the company hit the mid-point of its revenue guidance for FY22, despite the already flagged slowdown in volumes processed. The company continued to see strong... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 327 |
| EVOTEC | 291 |
| TUI | 209 |
| NVIDIA | 177 |
| DEUTSCHE BANK | 170 |
| BAYER | 154 |
| PLUG POWER | 143 |
| NEL | 133 |
| RHEINMETALL | 129 |
| SIEMENS ENERGY | 110 |
| BARRICK GOLD | 109 |
| COMMERZBANK | 107 |
| TESLA | 102 |
| BASF | 101 |
| VOLKSWAGEN | 93 |
| RWE | 89 |
| BYD | 87 |
| DEUTSCHE LUFTHANSA | 84 |
| ALLIANZ | 82 |
| RENK GROUP | 79 |
| MERCEDES-BENZ | 78 |
| DEUTSCHE TELEKOM | 75 |
| HEIDELBERGER DRUCK | 75 |
| ALIBABA | 71 |
| E.ON | 69 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
